(QLTY) The 2023 Series Trust II - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US90139K1007
QLTY: Common Stocks, Preferred Stocks, Convertible Securities, Depositary Receipts, Equity REITs, Income Trusts, Other Equity Investment Companies
The2023 ETF Series Trust II (NASDAQ:QLTY) is an actively managed exchange-traded fund that focuses on investing in high-quality U.S. equities. The funds adviser, Grantham, Mayo, Van Otterloo & Co. LLC (GMO), employs a rigorous selection process to identify top-tier companies. The investment portfolio comprises a diverse range of equity securities, including common and preferred stocks, as well as other stock-related instruments such as convertible securities and equity real estate investment trusts.
As a Large Blend ETF, QLTY is designed to provide broad exposure to the U.S. equity market, with a focus on high-quality companies. The funds assets under management (AUM) stand at approximately $1.863 billion, indicating a significant presence in the market. GMOs investment strategy is centered around identifying companies with strong fundamentals, which are expected to drive long-term growth and stability.
Analyzing the technical data, we observe that QLTYs last price is $33.17, with a 20-day simple moving average (SMA) of $32.67, indicating a positive trend. The 50-day SMA and 200-day SMA are $31.38 and $32.10, respectively, further supporting the bullish sentiment. The average true range (ATR) is 1.15%, suggesting moderate volatility. Given these technical indicators, we forecast that QLTY will continue to trend upwards, potentially reaching $35.00 in the near term, driven by the ongoing bullish momentum.
Combining the fundamental and technical analysis, we expect QLTY to maintain its upward trajectory, driven by GMOs expertise in identifying high-quality companies and the overall positive market sentiment. As the fund continues to attract assets, its AUM is likely to grow, further solidifying its position in the market. Our forecast suggests that QLTY will remain a strong contender in the Large Blend ETF category, with potential for long-term growth and stability.
Additional Sources for QLTY ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
QLTY ETF Overview
Market Cap in USD | 1,863m |
Category | Large Blend |
TER | 0.50% |
IPO / Inception | 2023-11-13 |
QLTY ETF Ratings
Growth Rating | 46.8 |
Fundamental | - |
Dividend Rating | 40.1 |
Rel. Strength | -1.97 |
Analysts | - |
Fair Price Momentum | 31.13 USD |
Fair Price DCF | - |
QLTY Dividends
Dividend Yield 12m | 0.78% |
Yield on Cost 5y | 1.02% |
Annual Growth 5y | 148.41% |
Payout Consistency | 66.7% |
Payout Ratio | % |
QLTY Growth Ratios
Growth Correlation 3m | 66.3% |
Growth Correlation 12m | 32.7% |
Growth Correlation 5y | 80.5% |
CAGR 5y | 19.81% |
CAGR/Max DD 5y | 1.17 |
Sharpe Ratio 12m | 1.04 |
Alpha | -1.55 |
Beta | 0.878 |
Volatility | 10.46% |
Current Volume | 160.6k |
Average Volume 20d | 137.7k |
As of June 15, 2025, the stock is trading at USD 33.17 with a total of 160,571 shares traded.
Over the past week, the price has changed by +0.61%, over one month by +2.41%, over three months by +7.13% and over the past year by +9.02%.
Partly, yes. Based on ValueRay´s Analyses, The 2023 Series Trust II (NASDAQ:QLTY) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 46.77 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of QLTY is around 31.13 USD . This means that QLTY is currently overvalued and has a potential downside of -6.15%.
The 2023 Series Trust II has no consensus analysts rating.
According to our own proprietary Forecast Model, QLTY The 2023 Series Trust II will be worth about 35.3 in June 2026. The stock is currently trading at 33.17. This means that the stock has a potential upside of +6.51%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 35.3 | 6.5% |